mTOR inhibitors are also effective in tumor types associated with RAS dysregulation; however, feedback signaling mediated by S6 kinase can increase AKT signaling, bypassing the inhibitory effects of the mTOR inhibitor (Sabatini, 2006). The gene discussed is MTOR; the disease is neoplasm.